Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

195
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
195
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

293
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
293
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

201
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic susceptibility to obesity-related asthma and its modulation by sequelae of obesity.

bioRxiv : the preprint server for biology·2026
Same author

Beyond the Trials: Real-World Insights into Tezepelumab Efficacy.

American journal of respiratory and critical care medicine·2026
Same author

Equity in Clinical Guidance on Application of Global Lung Function Initiative Guidelines for Pediatric Pulmonary Health Assessment.

Pediatrics·2026
Same author

Predicting Pediatric Asthma Readmissions Through Machine Learning: Performance With a National Administrative Database.

Pediatric pulmonology·2026
Same author

Asthma in Children With Melanocortin 4 Receptor (MC4R) Gene Mutation Variant: A Case Series.

Pediatric pulmonology·2026
Same author

Inflammatory Dysregulation, Asthma, and Obesity in Children: What is the Relationship?

Journal of inflammation research·2026

Related Experiment Video

Updated: May 20, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K

Non-T2 asthma.

Emily K Duffus1, Fernando Holguin2, Deepa Rastogi3

  • 1Rutgers University, Newark, New Jersey.

Current Opinion in Pulmonary Medicine
|March 24, 2025
PubMed
Summary

Non-T2 asthma is a diverse group of airway disorders lacking T2 biomarkers. Understanding its unique risk factors and immune mechanisms is crucial for effective management and treatment.

Area of Science:

  • Pulmonology
  • Immunology
  • Genetics

Background:

  • Asthma is a complex airway disorder with heterogeneous phenotypes.
  • Phenotypes are broadly classified as T2-high or non-T2 based on inflammatory biomarkers.
  • Non-T2 asthma is characterized by the absence or low levels of T2 biomarkers.

Purpose of the Study:

  • To provide a comprehensive overview of non-T2 asthma phenotypes.
  • To discuss the plasticity between T2 and non-T2 asthma mechanisms.
  • To explore risk factors, immunological, and metabolic mechanisms of non-T2 asthma.

Main Methods:

  • Review of current literature on non-T2 asthma.
  • Analysis of risk factors including viral infections, pollution, smoking, and genetic/metabolic factors.

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.3K

Related Experiment Videos

Last Updated: May 20, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.3K
  • Discussion of immunological and metabolic pathways in non-T2 asthma.

    • Main Results:

    • Non-T2 asthma is a heterogeneous group with later onset, often associated with obesity and females.
    • Risk factors for non-T2 asthma include viral infections, air pollution, smoking, and genetic/metabolic influences.
    • Distinct immunological and metabolic mechanisms underlie non-T2 asthma.

    Conclusions:

    • Non-T2 asthma represents a diverse set of phenotypes.
    • The absence of T2 biomarkers can be dynamic and influenced by factors like exacerbations, especially in children.
    • Tailored management strategies are needed for non-T2 asthma patients due to differing treatment responses.